Skip Navigation

A Phase IIIB, Multicenter, Open-label, PCI-32765 Ibrutinib Long-term Extension Study

Brief Summary

Type:
Leukemias

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT01804686

Study #:
STUDY00142597

Start Date:
Nov 13, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT01804686

View Complete Trial Details & Eligibility at ClinicalTrials.gov